3BFuture Health is a brand dedicated to transforming the lives of patients through innovative oncology treatments. Guided by their core values and driven by a passion for science, they leverage their expertise and network to bring about life-changing therapies. In 2016, they launched the Helsinn Investment Fund, which has since made investments in over 20 promising start-ups advancing novel therapies in areas of high unmet medical need.

With the success of their first fund, they re-branded as 3B Future Health Fund, focusing on Oncology and Rare Disease Therapeutics. This new fund is backed by the same proven team with industry experience and a network to advance promising projects from preclinical stages to the clinic and beyond. With a commitment to solid scientific and technological foundations, 3BFuture Health strives to provide new solutions for patients with few treatment options.

They actively participate in the strategic management of their portfolio companies, sharing their experience and network to build value. Contact them today to learn more about their transformative treatments